These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1976431)

  • 1. Pharmacotherapy of the borderline patient.
    Jerome L
    Can J Psychiatry; 1990 Aug; 35(6):572. PubMed ID: 1976431
    [No Abstract]   [Full Text] [Related]  

  • 2. The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol.
    Kutcher S; Papatheodorou G; Reiter S; Gardner D
    J Psychiatry Neurosci; 1995 Mar; 20(2):113-8. PubMed ID: 7703220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose antipsychotic drug use as a predictor for readmission of inpatients with borderline personality disorder: A retrospective chart review in a Japanese psychiatric hospital.
    Yamada Y; Yokoi Y; Narita Z; Hirabayashi N
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):365-370. PubMed ID: 33037872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic treatments for borderline personality disorder.
    Tohen M
    Am J Psychiatry; 2014 Nov; 171(11):1139-41. PubMed ID: 25756626
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aiming for the standardization of drug therapy for borderline personality disorders].
    Seishin Shinkeigaku Zasshi; 2007; 109(6):572-7. PubMed ID: 17939223
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic treatment in the borderline patient: advantages and techniques.
    Soloff PH
    J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole pharmacotherapy of borderline personality disorder.
    Mobascher A; Mobascher J; Schlemper V; Winterer G; Malevani J
    Pharmacopsychiatry; 2006 May; 39(3):111-2. PubMed ID: 16721700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of borderline personality disorder with atypical antipsychotic drugs].
    Mobascher A; Mobascher J; Schmahl C; Malevani J
    Nervenarzt; 2007 Sep; 78(9):1003-13. PubMed ID: 17294149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for borderline personality disorder: NICE guideline.
    Kendall T; Burbeck R; Bateman A
    Br J Psychiatry; 2010 Feb; 196(2):158-9. PubMed ID: 20118465
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of outpatients with borderline personality disorder.
    Sweeney DR
    J Clin Psychiatry; 1987 Aug; 48 Suppl():32-7. PubMed ID: 2886495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychopharmacology of borderline personality disorders.
    Montgomery SA
    Acta Psychiatr Belg; 1987; 87(3):260-6. PubMed ID: 3673629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
    Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A
    J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695
    [No Abstract]   [Full Text] [Related]  

  • 13. Cariprazine treatment of borderline personality disorder: A case report.
    Grant JE; Chamberlain SR
    Psychiatry Clin Neurosci; 2020 Sep; 74(9):511-512. PubMed ID: 32588527
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
    Kutcher SP; Blackwood DH
    Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Acting Aripiprazole in Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Abuse.
    Martínez JS; Caballero AR
    J Clin Psychopharmacol; 2017 Apr; 37(2):266-267. PubMed ID: 28145998
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial.
    Black DW; Zanarini MC; Romine A; Shaw M; Allen J; Schulz SC
    Am J Psychiatry; 2014 Nov; 171(11):1174-82. PubMed ID: 24968985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled Loxapine for Acute Treatment of Agitation in Patients With Borderline Personality Disorder: A Case Series.
    Kahl KG; Negt P; Wollmer A; Jung S; Kruger TH
    J Clin Psychopharmacol; 2015 Dec; 35(6):741-3. PubMed ID: 26448403
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacotherapy in the treatment of borderline personality disorder].
    Alliani D; Tarantelli S
    Riv Psichiatr; 2009; 44(6):357-73. PubMed ID: 20218215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacotherapy of a 67-year old female with borderline personality disorder].
    Schulkens JEM; Sobczak S; van Alphen SPJ
    Tijdschr Gerontol Geriatr; 2020 Jun; 51(2):. PubMed ID: 32951381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.